Click for best price
Diabetic Therapeutic Drugs Market Size, Share 2022
This report contains market size and forecasts of Diabetic Therapeutic Drugs in global, including the following market information:
Global Diabetic Therapeutic Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Diabetic Therapeutic Drugs Market Sales, 2017-2022, 2023-2028, (MT)
Global top five Diabetic Therapeutic Drugs companies in 2021 (%)
The global Diabetic Therapeutic Drugs market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Insulin Therapies Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Diabetic Therapeutic Drugs include AstraZeneca, Eli Lilly, Merck, Novo Nordisk, Sanofi, Pfizer, Novartis, Perle Biosciences and Sun Pharma, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Diabetic Therapeutic Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Diabetic Therapeutic Drugs Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (MT)
Global Diabetic Therapeutic Drugs Market Segment Percentages, by Type, 2021 (%)
Insulin Therapies
Non-Insulin Therapies
Global Diabetic Therapeutic Drugs Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (MT)
Global Diabetic Therapeutic Drugs Market Segment Percentages, by Application, 2021 (%)
Type 1 Diabetes
Type 2 Diabetes
Gestational Diabetes
Global Diabetic Therapeutic Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (MT)
Global Diabetic Therapeutic Drugs Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Diabetic Therapeutic Drugs revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Diabetic Therapeutic Drugs revenues share in global market, 2021 (%)
Key companies Diabetic Therapeutic Drugs sales in global market, 2017-2022 (Estimated), (MT)
Key companies Diabetic Therapeutic Drugs sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
AstraZeneca
Eli Lilly
Merck
Novo Nordisk
Sanofi
Pfizer
Novartis
Perle Biosciences
Sun Pharma
Takeda Pharmaceuticals
F. Hoffmann-La Roche
Belrose Pharma
Mitsubishi Tanabe Pharma
Dong-A ST
Eisai
Arbutus Biopharma
| Report Attributes |
Report Details |
| Report Title |
Diabetic Therapeutic Drugs Market, Global Outlook and Forecast 2022-2028 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2021 |
| Forecast Year |
2029 |
| Number of Pages |
110 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Diabetic Therapeutic Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Diabetic Therapeutic Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Diabetic Therapeutic Drugs Overall Market Size
2.1 Global Diabetic Therapeutic Drugs Market Size: 2021 VS 2028
2.2 Global Diabetic Therapeutic Drugs Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Diabetic Therapeutic Drugs Sales: 2017-2028
3 Company Landscape
3.1 Top Diabetic Therapeutic Drugs Players in Global Market
3.2 Top Global Diabetic Therapeutic Drugs Companies Ranked by Revenue
3.3 Global Diabetic Therapeutic Drugs Revenue by Companies
3.4 Global Diabetic Therapeutic Drugs Sales by Companies
3.5 Global Diabetic Therapeutic Drugs Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Diabetic Therapeutic Drugs Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Diabetic Therapeutic Drugs Product Type
3.8 Tier 1, Tier 2 and Tier 3 Diabetic Therapeutic Drugs Players in Global Market
3.8.1 List of Global Tier 1 Diabetic Therapeutic Drugs Companies
3.8.2 List of Global Tier 2 and Tier 3 Diabetic Therapeutic Drugs Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Diabetic Therapeutic Drugs Market Size Markets, 2021 & 2028
4.1.2 Insulin Therapies
4.1.3 Non-Insulin Therapies
4.2 By Type - Global Diabetic Therapeutic Drugs Revenue & Forecasts
4.2.1 By Type - Global Diabetic Therapeutic Drugs Revenue, 2017-2022
4.2.2 By Type - Global Diabetic Therapeutic Drugs Revenue, 2023-2028
4.2.3 By Type - Global Diabetic Therapeutic Drugs Revenue Market Share, 2017-2028
4.3 By Type - Global Diabetic Therapeutic Drugs Sales & Forecasts
4.3.1 By Type - Global Diabetic Therapeutic Drugs Sales, 2017-2022
4.3.2 By Type - Global Diabetic Therapeutic Drugs Sales, 2023-2028
4.3.3 By Type - Global Diabetic Therapeutic Drugs Sales Market Share, 2017-2028
4.4 By Type - Global Diabetic Therapeutic Drugs Price (Manufacturers Selling Prices), 2017-2028
5 Sights By Application
5.1 Overview
5.1.1 By Application - Global Diabetic Therapeutic Drugs Market Size, 2021 & 2028
5.1.2 Type 1 Diabetes
5.1.3 Type 2 Diabetes
5.1.4 Gestational Diabetes
5.2 By Application - Global Diabetic Therapeutic Drugs Revenue & Forecasts
5.2.1 By Application - Global Diabetic Therapeutic Drugs Revenue, 2017-2022
5.2.2 By Application - Global Diabetic Therapeutic Drugs Revenue, 2023-2028
5.2.3 By Application - Global Diabetic Therapeutic Drugs Revenue Market Share, 2017-2028
5.3 By Application - Global Diabetic Therapeutic Drugs Sales & Forecasts
5.3.1 By Application - Global Diabetic Therapeutic Drugs Sales, 2017-2022
5.3.2 By Application - Global Diabetic Therapeutic Drugs Sales, 2023-2028
5.3.3 By Application - Global Diabetic Therapeutic Drugs Sales Market Share, 2017-2028
5.4 By Application - Global Diabetic Therapeutic Drugs Price (Manufacturers Selling Prices), 2017-2028
6 Sights by Region
6.1 By Region - Global Diabetic Therapeutic Drugs Market Size, 2021 & 2028
6.2 By Region - Global Diabetic Therapeutic Drugs Revenue & Forecasts
6.2.1 By Region - Global Diabetic Therapeutic Drugs Revenue, 2017-2022
6.2.2 By Region - Global Diabetic Therapeutic Drugs Revenue, 2023-2028
6.2.3 By Region - Global Diabetic Therapeutic Drugs Revenue Market Share, 2017-2028
6.3 By Region - Global Diabetic Therapeutic Drugs Sales & Forecasts
6.3.1 By Region - Global Diabetic Therapeutic Drugs Sales, 2017-2022
6.3.2 By Region - Global Diabetic Therapeutic Drugs Sales, 2023-2028
6.3.3 By Region - Global Diabetic Therapeutic Drugs Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Diabetic Therapeutic Drugs Revenue, 2017-2028
6.4.2 By Country - North America Diabetic Therapeutic Drugs Sales, 2017-2028
6.4.3 US Diabetic Therapeutic Drugs Market Size, 2017-2028
6.4.4 Canada Diabetic Therapeutic Drugs Market Size, 2017-2028
6.4.5 Mexico Diabetic Therapeutic Drugs Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Diabetic Therapeutic Drugs Revenue, 2017-2028
6.5.2 By Country - Europe Diabetic Therapeutic Drugs Sales, 2017-2028
6.5.3 Germany Diabetic Therapeutic Drugs Market Size, 2017-2028
6.5.4 France Diabetic Therapeutic Drugs Market Size, 2017-2028
6.5.5 U.K. Diabetic Therapeutic Drugs Market Size, 2017-2028
6.5.6 Italy Diabetic Therapeutic Drugs Market Size, 2017-2028
6.5.7 Russia Diabetic Therapeutic Drugs Market Size, 2017-2028
6.5.8 Nordic Countries Diabetic Therapeutic Drugs Market Size, 2017-2028
6.5.9 Benelux Diabetic Therapeutic Drugs Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Diabetic Therapeutic Drugs Revenue, 2017-2028
6.6.2 By Region - Asia Diabetic Therapeutic Drugs Sales, 2017-2028
6.6.3 China Diabetic Therapeutic Drugs Market Size, 2017-2028
6.6.4 Japan Diabetic Therapeutic Drugs Market Size, 2017-2028
6.6.5 South Korea Diabetic Therapeutic Drugs Market Size, 2017-2028
6.6.6 Southeast Asia Diabetic Therapeutic Drugs Market Size, 2017-2028
6.6.7 India Diabetic Therapeutic Drugs Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Diabetic Therapeutic Drugs Revenue, 2017-2028
6.7.2 By Country - South America Diabetic Therapeutic Drugs Sales, 2017-2028
6.7.3 Brazil Diabetic Therapeutic Drugs Market Size, 2017-2028
6.7.4 Argentina Diabetic Therapeutic Drugs Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Diabetic Therapeutic Drugs Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Diabetic Therapeutic Drugs Sales, 2017-2028
6.8.3 Turkey Diabetic Therapeutic Drugs Market Size, 2017-2028
6.8.4 Israel Diabetic Therapeutic Drugs Market Size, 2017-2028
6.8.5 Saudi Arabia Diabetic Therapeutic Drugs Market Size, 2017-2028
6.8.6 UAE Diabetic Therapeutic Drugs Market Size, 2017-2028
7 Manufacturers & Brands Profiles
7.1 AstraZeneca
7.1.1 AstraZeneca Corporate Summary
7.1.2 AstraZeneca Business Overview
7.1.3 AstraZeneca Diabetic Therapeutic Drugs Major Product Offerings
7.1.4 AstraZeneca Diabetic Therapeutic Drugs Sales and Revenue in Global (2017-2022)
7.1.5 AstraZeneca Key News
7.2 Eli Lilly
7.2.1 Eli Lilly Corporate Summary
7.2.2 Eli Lilly Business Overview
7.2.3 Eli Lilly Diabetic Therapeutic Drugs Major Product Offerings
7.2.4 Eli Lilly Diabetic Therapeutic Drugs Sales and Revenue in Global (2017-2022)
7.2.5 Eli Lilly Key News
7.3 Merck
7.3.1 Merck Corporate Summary
7.3.2 Merck Business Overview
7.3.3 Merck Diabetic Therapeutic Drugs Major Product Offerings
7.3.4 Merck Diabetic Therapeutic Drugs Sales and Revenue in Global (2017-2022)
7.3.5 Merck Key News
7.4 Novo Nordisk
7.4.1 Novo Nordisk Corporate Summary
7.4.2 Novo Nordisk Business Overview
7.4.3 Novo Nordisk Diabetic Therapeutic Drugs Major Product Offerings
7.4.4 Novo Nordisk Diabetic Therapeutic Drugs Sales and Revenue in Global (2017-2022)
7.4.5 Novo Nordisk Key News
7.5 Sanofi
7.5.1 Sanofi Corporate Summary
7.5.2 Sanofi Business Overview
7.5.3 Sanofi Diabetic Therapeutic Drugs Major Product Offerings
7.5.4 Sanofi Diabetic Therapeutic Drugs Sales and Revenue in Global (2017-2022)
7.5.5 Sanofi Key News
7.6 Pfizer
7.6.1 Pfizer Corporate Summary
7.6.2 Pfizer Business Overview
7.6.3 Pfizer Diabetic Therapeutic Drugs Major Product Offerings
7.6.4 Pfizer Diabetic Therapeutic Drugs Sales and Revenue in Global (2017-2022)
7.6.5 Pfizer Key News
7.7 Novartis
7.7.1 Novartis Corporate Summary
7.7.2 Novartis Business Overview
7.7.3 Novartis Diabetic Therapeutic Drugs Major Product Offerings
7.7.4 Novartis Diabetic Therapeutic Drugs Sales and Revenue in Global (2017-2022)
7.7.5 Novartis Key News
7.8 Perle Biosciences
7.8.1 Perle Biosciences Corporate Summary
7.8.2 Perle Biosciences Business Overview
7.8.3 Perle Biosciences Diabetic Therapeutic Drugs Major Product Offerings
7.8.4 Perle Biosciences Diabetic Therapeutic Drugs Sales and Revenue in Global (2017-2022)
7.8.5 Perle Biosciences Key News
7.9 Sun Pharma
7.9.1 Sun Pharma Corporate Summary
7.9.2 Sun Pharma Business Overview
7.9.3 Sun Pharma Diabetic Therapeutic Drugs Major Product Offerings
7.9.4 Sun Pharma Diabetic Therapeutic Drugs Sales and Revenue in Global (2017-2022)
7.9.5 Sun Pharma Key News
7.10 Takeda Pharmaceuticals
7.10.1 Takeda Pharmaceuticals Corporate Summary
7.10.2 Takeda Pharmaceuticals Business Overview
7.10.3 Takeda Pharmaceuticals Diabetic Therapeutic Drugs Major Product Offerings
7.10.4 Takeda Pharmaceuticals Diabetic Therapeutic Drugs Sales and Revenue in Global (2017-2022)
7.10.5 Takeda Pharmaceuticals Key News
7.11 F. Hoffmann-La Roche
7.11.1 F. Hoffmann-La Roche Corporate Summary
7.11.2 F. Hoffmann-La Roche Diabetic Therapeutic Drugs Business Overview
7.11.3 F. Hoffmann-La Roche Diabetic Therapeutic Drugs Major Product Offerings
7.11.4 F. Hoffmann-La Roche Diabetic Therapeutic Drugs Sales and Revenue in Global (2017-2022)
7.11.5 F. Hoffmann-La Roche Key News
7.12 Belrose Pharma
7.12.1 Belrose Pharma Corporate Summary
7.12.2 Belrose Pharma Diabetic Therapeutic Drugs Business Overview
7.12.3 Belrose Pharma Diabetic Therapeutic Drugs Major Product Offerings
7.12.4 Belrose Pharma Diabetic Therapeutic Drugs Sales and Revenue in Global (2017-2022)
7.12.5 Belrose Pharma Key News
7.13 Mitsubishi Tanabe Pharma
7.13.1 Mitsubishi Tanabe Pharma Corporate Summary
7.13.2 Mitsubishi Tanabe Pharma Diabetic Therapeutic Drugs Business Overview
7.13.3 Mitsubishi Tanabe Pharma Diabetic Therapeutic Drugs Major Product Offerings
7.13.4 Mitsubishi Tanabe Pharma Diabetic Therapeutic Drugs Sales and Revenue in Global (2017-2022)
7.13.5 Mitsubishi Tanabe Pharma Key News
7.14 Dong-A ST
7.14.1 Dong-A ST Corporate Summary
7.14.2 Dong-A ST Business Overview
7.14.3 Dong-A ST Diabetic Therapeutic Drugs Major Product Offerings
7.14.4 Dong-A ST Diabetic Therapeutic Drugs Sales and Revenue in Global (2017-2022)
7.14.5 Dong-A ST Key News
7.15 Eisai
7.15.1 Eisai Corporate Summary
7.15.2 Eisai Business Overview
7.15.3 Eisai Diabetic Therapeutic Drugs Major Product Offerings
7.15.4 Eisai Diabetic Therapeutic Drugs Sales and Revenue in Global (2017-2022)
7.15.5 Eisai Key News
7.16 Arbutus Biopharma
7.16.1 Arbutus Biopharma Corporate Summary
7.16.2 Arbutus Biopharma Business Overview
7.16.3 Arbutus Biopharma Diabetic Therapeutic Drugs Major Product Offerings
7.16.4 Arbutus Biopharma Diabetic Therapeutic Drugs Sales and Revenue in Global (2017-2022)
7.16.5 Arbutus Biopharma Key News
8 Global Diabetic Therapeutic Drugs Production Capacity, Analysis
8.1 Global Diabetic Therapeutic Drugs Production Capacity, 2017-2028
8.2 Diabetic Therapeutic Drugs Production Capacity of Key Manufacturers in Global Market
8.3 Global Diabetic Therapeutic Drugs Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Diabetic Therapeutic Drugs Supply Chain Analysis
10.1 Diabetic Therapeutic Drugs Industry Value Chain
10.2 Diabetic Therapeutic Drugs Upstream Market
10.3 Diabetic Therapeutic Drugs Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Diabetic Therapeutic Drugs Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Diabetic Therapeutic Drugs in Global Market
Table 2. Top Diabetic Therapeutic Drugs Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Diabetic Therapeutic Drugs Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Diabetic Therapeutic Drugs Revenue Share by Companies, 2017-2022
Table 5. Global Diabetic Therapeutic Drugs Sales by Companies, (MT), 2017-2022
Table 6. Global Diabetic Therapeutic Drugs Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Diabetic Therapeutic Drugs Price (2017-2022) & (USD/Kg)
Table 8. Global Manufacturers Diabetic Therapeutic Drugs Product Type
Table 9. List of Global Tier 1 Diabetic Therapeutic Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Diabetic Therapeutic Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type ? Global Diabetic Therapeutic Drugs Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Diabetic Therapeutic Drugs Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Diabetic Therapeutic Drugs Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Diabetic Therapeutic Drugs Sales (MT), 2017-2022
Table 15. By Type - Global Diabetic Therapeutic Drugs Sales (MT), 2023-2028
Table 16. By Application ? Global Diabetic Therapeutic Drugs Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Diabetic Therapeutic Drugs Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Diabetic Therapeutic Drugs Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Diabetic Therapeutic Drugs Sales (MT), 2017-2022
Table 20. By Application - Global Diabetic Therapeutic Drugs Sales (MT), 2023-2028
Table 21. By Region ? Global Diabetic Therapeutic Drugs Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Diabetic Therapeutic Drugs Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Diabetic Therapeutic Drugs Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Diabetic Therapeutic Drugs Sales (MT), 2017-2022
Table 25. By Region - Global Diabetic Therapeutic Drugs Sales (MT), 2023-2028
Table 26. By Country - North America Diabetic Therapeutic Drugs Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Diabetic Therapeutic Drugs Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Diabetic Therapeutic Drugs Sales, (MT), 2017-2022
Table 29. By Country - North America Diabetic Therapeutic Drugs Sales, (MT), 2023-2028
Table 30. By Country - Europe Diabetic Therapeutic Drugs Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Diabetic Therapeutic Drugs Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Diabetic Therapeutic Drugs Sales, (MT), 2017-2022
Table 33. By Country - Europe Diabetic Therapeutic Drugs Sales, (MT), 2023-2028
Table 34. By Region - Asia Diabetic Therapeutic Drugs Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Diabetic Therapeutic Drugs Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Diabetic Therapeutic Drugs Sales, (MT), 2017-2022
Table 37. By Region - Asia Diabetic Therapeutic Drugs Sales, (MT), 2023-2028
Table 38. By Country - South America Diabetic Therapeutic Drugs Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Diabetic Therapeutic Drugs Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Diabetic Therapeutic Drugs Sales, (MT), 2017-2022
Table 41. By Country - South America Diabetic Therapeutic Drugs Sales, (MT), 2023-2028
Table 42. By Country - Middle East & Africa Diabetic Therapeutic Drugs Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Diabetic Therapeutic Drugs Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Diabetic Therapeutic Drugs Sales, (MT), 2017-2022
Table 45. By Country - Middle East & Africa Diabetic Therapeutic Drugs Sales, (MT), 2023-2028
Table 46. AstraZeneca Corporate Summary
Table 47. AstraZeneca Diabetic Therapeutic Drugs Product Offerings
Table 48. AstraZeneca Diabetic Therapeutic Drugs Sales (MT), Revenue (US$, Mn) and Average Price (USD/Kg) (2017-2022)
Table 49. Eli Lilly Corporate Summary
Table 50. Eli Lilly Diabetic Therapeutic Drugs Product Offerings
Table 51. Eli Lilly Diabetic Therapeutic Drugs Sales (MT), Revenue (US$, Mn) and Average Price (USD/Kg) (2017-2022)
Table 52. Merck Corporate Summary
Table 53. Merck Diabetic Therapeutic Drugs Product Offerings
Table 54. Merck Diabetic Therapeutic Drugs Sales (MT), Revenue (US$, Mn) and Average Price (USD/Kg) (2017-2022)
Table 55. Novo Nordisk Corporate Summary
Table 56. Novo Nordisk Diabetic Therapeutic Drugs Product Offerings
Table 57. Novo Nordisk Diabetic Therapeutic Drugs Sales (MT), Revenue (US$, Mn) and Average Price (USD/Kg) (2017-2022)
Table 58. Sanofi Corporate Summary
Table 59. Sanofi Diabetic Therapeutic Drugs Product Offerings
Table 60. Sanofi Diabetic Therapeutic Drugs Sales (MT), Revenue (US$, Mn) and Average Price (USD/Kg) (2017-2022)
Table 61. Pfizer Corporate Summary
Table 62. Pfizer Diabetic Therapeutic Drugs Product Offerings
Table 63. Pfizer Diabetic Therapeutic Drugs Sales (MT), Revenue (US$, Mn) and Average Price (USD/Kg) (2017-2022)
Table 64. Novartis Corporate Summary
Table 65. Novartis Diabetic Therapeutic Drugs Product Offerings
Table 66. Novartis Diabetic Therapeutic Drugs Sales (MT), Revenue (US$, Mn) and Average Price (USD/Kg) (2017-2022)
Table 67. Perle Biosciences Corporate Summary
Table 68. Perle Biosciences Diabetic Therapeutic Drugs Product Offerings
Table 69. Perle Biosciences Diabetic Therapeutic Drugs Sales (MT), Revenue (US$, Mn) and Average Price (USD/Kg) (2017-2022)
Table 70. Sun Pharma Corporate Summary
Table 71. Sun Pharma Diabetic Therapeutic Drugs Product Offerings
Table 72. Sun Pharma Diabetic Therapeutic Drugs Sales (MT), Revenue (US$, Mn) and Average Price (USD/Kg) (2017-2022)
Table 73. Takeda Pharmaceuticals Corporate Summary
Table 74. Takeda Pharmaceuticals Diabetic Therapeutic Drugs Product Offerings
Table 75. Takeda Pharmaceuticals Diabetic Therapeutic Drugs Sales (MT), Revenue (US$, Mn) and Average Price (USD/Kg) (2017-2022)
Table 76. F. Hoffmann-La Roche Corporate Summary
Table 77. F. Hoffmann-La Roche Diabetic Therapeutic Drugs Product Offerings
Table 78. F. Hoffmann-La Roche Diabetic Therapeutic Drugs Sales (MT), Revenue (US$, Mn) and Average Price (USD/Kg) (2017-2022)
Table 79. Belrose Pharma Corporate Summary
Table 80. Belrose Pharma Diabetic Therapeutic Drugs Product Offerings
Table 81. Belrose Pharma Diabetic Therapeutic Drugs Sales (MT), Revenue (US$, Mn) and Average Price (USD/Kg) (2017-2022)
Table 82. Mitsubishi Tanabe Pharma Corporate Summary
Table 83. Mitsubishi Tanabe Pharma Diabetic Therapeutic Drugs Product Offerings
Table 84. Mitsubishi Tanabe Pharma Diabetic Therapeutic Drugs Sales (MT), Revenue (US$, Mn) and Average Price (USD/Kg) (2017-2022)
Table 85. Dong-A ST Corporate Summary
Table 86. Dong-A ST Diabetic Therapeutic Drugs Product Offerings
Table 87. Dong-A ST Diabetic Therapeutic Drugs Sales (MT), Revenue (US$, Mn) and Average Price (USD/Kg) (2017-2022)
Table 88. Eisai Corporate Summary
Table 89. Eisai Diabetic Therapeutic Drugs Product Offerings
Table 90. Eisai Diabetic Therapeutic Drugs Sales (MT), Revenue (US$, Mn) and Average Price (USD/Kg) (2017-2022)
Table 91. Arbutus Biopharma Corporate Summary
Table 92. Arbutus Biopharma Diabetic Therapeutic Drugs Product Offerings
Table 93. Arbutus Biopharma Diabetic Therapeutic Drugs Sales (MT), Revenue (US$, Mn) and Average Price (USD/Kg) (2017-2022)
Table 94. Diabetic Therapeutic Drugs Production Capacity (MT) of Key Manufacturers in Global Market, 2020-2022 (MT)
Table 95. Global Diabetic Therapeutic Drugs Capacity Market Share of Key Manufacturers, 2020-2022
Table 96. Global Diabetic Therapeutic Drugs Production by Region, 2017-2022 (MT)
Table 97. Global Diabetic Therapeutic Drugs Production by Region, 2023-2028 (MT)
Table 98. Diabetic Therapeutic Drugs Market Opportunities & Trends in Global Market
Table 99. Diabetic Therapeutic Drugs Market Drivers in Global Market
Table 100. Diabetic Therapeutic Drugs Market Restraints in Global Market
Table 101. Diabetic Therapeutic Drugs Raw Materials
Table 102. Diabetic Therapeutic Drugs Raw Materials Suppliers in Global Market
Table 103. Typical Diabetic Therapeutic Drugs Downstream
Table 104. Diabetic Therapeutic Drugs Downstream Clients in Global Market
Table 105. Diabetic Therapeutic Drugs Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Diabetic Therapeutic Drugs Segment by Type
Figure 2. Diabetic Therapeutic Drugs Segment by Application
Figure 3. Global Diabetic Therapeutic Drugs Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Diabetic Therapeutic Drugs Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Diabetic Therapeutic Drugs Revenue, 2017-2028 (US$, Mn)
Figure 7. Diabetic Therapeutic Drugs Sales in Global Market: 2017-2028 (MT)
Figure 8. The Top 3 and 5 Players Market Share by Diabetic Therapeutic Drugs Revenue in 2021
Figure 9. By Type - Global Diabetic Therapeutic Drugs Sales Market Share, 2017-2028
Figure 10. By Type - Global Diabetic Therapeutic Drugs Revenue Market Share, 2017-2028
Figure 11. By Type - Global Diabetic Therapeutic Drugs Price (USD/Kg), 2017-2028
Figure 12. By Application - Global Diabetic Therapeutic Drugs Sales Market Share, 2017-2028
Figure 13. By Application - Global Diabetic Therapeutic Drugs Revenue Market Share, 2017-2028
Figure 14. By Application - Global Diabetic Therapeutic Drugs Price (USD/Kg), 2017-2028
Figure 15. By Region - Global Diabetic Therapeutic Drugs Sales Market Share, 2017-2028
Figure 16. By Region - Global Diabetic Therapeutic Drugs Revenue Market Share, 2017-2028
Figure 17. By Country - North America Diabetic Therapeutic Drugs Revenue Market Share, 2017-2028
Figure 18. By Country - North America Diabetic Therapeutic Drugs Sales Market Share, 2017-2028
Figure 19. US Diabetic Therapeutic Drugs Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Diabetic Therapeutic Drugs Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Diabetic Therapeutic Drugs Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Diabetic Therapeutic Drugs Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Diabetic Therapeutic Drugs Sales Market Share, 2017-2028
Figure 24. Germany Diabetic Therapeutic Drugs Revenue, (US$, Mn), 2017-2028
Figure 25. France Diabetic Therapeutic Drugs Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Diabetic Therapeutic Drugs Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Diabetic Therapeutic Drugs Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Diabetic Therapeutic Drugs Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Diabetic Therapeutic Drugs Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Diabetic Therapeutic Drugs Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Diabetic Therapeutic Drugs Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Diabetic Therapeutic Drugs Sales Market Share, 2017-2028
Figure 33. China Diabetic Therapeutic Drugs Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Diabetic Therapeutic Drugs Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Diabetic Therapeutic Drugs Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Diabetic Therapeutic Drugs Revenue, (US$, Mn), 2017-2028
Figure 37. India Diabetic Therapeutic Drugs Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Diabetic Therapeutic Drugs Revenue Market Share, 2017-2028
Figure 39. By Country - South America Diabetic Therapeutic Drugs Sales Market Share, 2017-2028
Figure 40. Brazil Diabetic Therapeutic Drugs Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Diabetic Therapeutic Drugs Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Diabetic Therapeutic Drugs Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Diabetic Therapeutic Drugs Sales Market Share, 2017-2028
Figure 44. Turkey Diabetic Therapeutic Drugs Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Diabetic Therapeutic Drugs Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Diabetic Therapeutic Drugs Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Diabetic Therapeutic Drugs Revenue, (US$, Mn), 2017-2028
Figure 48. Global Diabetic Therapeutic Drugs Production Capacity (MT), 2017-2028
Figure 49. The Percentage of Production Diabetic Therapeutic Drugs by Region, 2021 VS 2028
Figure 50. Diabetic Therapeutic Drugs Industry Value Chain
Figure 51. Marketing Channels
